（文章来源：新华社） 中共中央政治局委员、国务院副总理何立峰10日下午会见美国雅培公司、英国保诚集团、韩国SK集团 等知名跨国公司负责人，就全球和中国经济形势、扩大对华投资等交换意见。何立峰表示，中国经济基 础稳、优势多、韧性强、潜能大，长期向好的支撑条件和基本趋势没有变。中国将持续扩大高水平对外 开放，欢迎跨国企业扩大在华投资，深化对华合作，共享发展机遇。跨国公司负责人表示看好中国经济 前景，将继续深耕中国市场，进一步扩大对华合作。 ...

Group 1 - Major financial institutions such as JPMorgan Chase & Co., Wells Fargo & Company, Goldman Sachs Group Inc., BlackRock Inc., and Citigroup Inc. are set to report earnings next Tuesday pre-market [1] - Following the major financials, Bank of America Corporation and Morgan Stanley will report earnings next Wednesday [1] - Taiwan Semiconductor Manufacturing Company Ltd., a key player in the tech sector, will report earnings next Thursday pre-market [1] Group 2 - Significant earnings reports earlier in the week include PepsiCo Inc. on Thursday before the market opens and Johnson & Johnson next Tuesday pre-market [1] - ASML Holding N.V. is also expected to release important technology earnings next Wednesday pre-market, alongside healthcare leader Abbott Laboratories [1]

Abbott Laboratories (NYSE: ABT ) is expected to report its Q3 earnings on Wednesday next week. Back when the company released its previous results, FY25'Q2, on the 17th of July, ABT stock dropped almost 9%, from $131 to $120. This selloff had comeI specialize in analyzing individual stocks. With a strong educational background in both finance and economics, I’ve developed a deep fascination with the stock market and the potential it offers to investors at all levels. I keep a close watch on market trends, p ...

Ever since spinning off from Abbott Laboratories in 2013, AbbVie has made culture a strategic business priority.  The logic is sound for a business that relies on the skill and ideas of its people to find and develop new drug candidates, which is vital for long-term growth in pharmaceuticals.  “We think sustained performance will be driven by a consistent culture,” explains Jason Smith, AbbVie’s senior vice president and head of Europe commercial operations.  “We’re not looking for a one- or two-year view o ...

"跨国企业的选择具有风向标意义，表明对中国市场的认识逐步回归到原有的经济逻辑——看重市 场潜力、营商环境与供应链完整等。"市咨会顾问、安永亚太区人力资源主管合伙人黄文告诉记者，市 咨会不仅是上海学习世界的机会，更将成为世界了解中国的契机。这场城企之间的互动，犹如十月的上 海，空气中透着收获的味道。 不只是成员扩充 记者 洪俊杰 在复杂的国际政治环境下，全球顶尖企业还要不要中国市场？即将举行的第37次上海市市长国际企 业家咨询会议，给世界一个明确答案—— 国际企业家报名踊跃，如今市咨会成员数已达46名，其中的40位全球顶尖企业家已确定今年来沪参 会。 作为"开放前沿"小组主持人，雅培公司董事长兼首席执行官罗赋德介绍，希望通过今年市咨会，与 上海朋友共同探索医疗创新的无限可能，通过持续开展跨地区、跨文化、跨领域的深度交流和合作，加 速突破创新边界，促进全行业开放发展。 讲真心话，一直是市咨会讨论的特点，有的与会企业家甚至把中国区总裁请出会场，"我有悄悄话 要跟上海市长说"。亲历者回忆讨论场景——市领导接连提问、国际企业家坦率回答，话题涵盖上海营 商环境、缩短负面清单、实施审慎监管等。有的企业家甚至开玩笑说："我说 ...

Core Insights - Artificial intelligence (AI) is identified as the greatest investment opportunity of the current era, with a strong emphasis on the urgent need for energy to support its growth [1][2][3] - A specific company is highlighted as a key player in the AI energy sector, owning critical energy infrastructure assets that are essential for meeting the increasing energy demands of AI technologies [3][7] Investment Landscape - Wall Street is investing hundreds of billions into AI, but there is a pressing concern regarding the energy supply needed to sustain this growth [2] - AI data centers, such as those powering large language models, consume energy equivalent to that of small cities, indicating a significant strain on global power grids [2] Company Profile - The company in focus is not a chipmaker or cloud platform but is positioned as a crucial player in the energy sector, particularly in nuclear energy infrastructure [7] - It is capable of executing large-scale engineering, procurement, and construction (EPC) projects across various energy sectors, including oil, gas, and renewable fuels [7] Financial Position - The company is noted for being completely debt-free and holding a substantial cash reserve, which is nearly one-third of its market capitalization [8] - It is trading at less than 7 times earnings, making it an attractive investment opportunity compared to other firms in the energy and utility sectors [10] Market Trends - The company is poised to benefit from the onshoring trend driven by tariffs, as well as the surge in U.S. LNG exports under the current administration's energy policies [5][14] - There is a growing recognition on Wall Street of this company's potential, as it quietly capitalizes on multiple favorable market trends without the high valuations seen in other sectors [8][6] Future Outlook - The demand for AI is expected to continue growing, leading to an increased need for energy infrastructure, which the company is well-positioned to provide [3][12] - The influx of talent into the AI sector is anticipated to drive rapid advancements, further solidifying the importance of energy infrastructure in supporting this growth [12]

Company Performance - Abbott's stock closed at $134.59, reflecting a +1.2% increase from the previous day, outperforming the S&P 500's gain of 0.01% [1] - Over the past month, Abbott's shares have appreciated by 0.14%, underperforming the Medical sector's gain of 4.67% and the S&P 500's gain of 4.83% [1] Upcoming Earnings - Abbott is set to release its earnings report on October 15, 2025, with an expected EPS of $1.3, indicating a 7.44% growth year-over-year [2] - The consensus estimate for revenue is $11.42 billion, reflecting a 7.4% increase compared to the same quarter last year [2] Annual Estimates - For the annual period, Zacks Consensus Estimates project earnings of $5.15 per share and revenue of $44.68 billion, representing increases of +10.28% and +6.5% respectively from the previous year [3] - Recent changes to analyst estimates for Abbott indicate evolving short-term business trends, with positive revisions suggesting analysts' confidence in the company's performance [3] Valuation Metrics - Abbott's current Forward P/E ratio is 25.83, which is a premium compared to the industry average of 18.31 [6] - The PEG ratio for Abbott stands at 2.52, compared to the industry average PEG ratio of 2.27 [6] Industry Context - The Medical - Products industry, which includes Abbott, has a Zacks Industry Rank of 77, placing it in the top 32% of over 250 industries [7] - Strong individual industry groups, as measured by the Zacks Industry Rank, tend to outperform weaker groups by a factor of 2 to 1 [7]

Core Viewpoint - Abbott Laboratories (NYSE:ABT) is highlighted as a top choice for retirement portfolios, with UBS maintaining a Buy rating and a price target of $154, emphasizing confidence in the company's growth trajectory, particularly in its MedTech division which is expected to sustain growth rates of 10% or more [1][2]. Group 1: Company Performance - Abbott Laboratories is recognized as a leading global healthcare company that produces a diverse range of products including branded generic medications, medical devices, diagnostics, and nutritional items [3]. - UBS anticipates that Abbott will outperform competitors in margin expansion and earnings per share growth, with the stock currently trading at approximately 23 times the consensus earnings per share for 2026, which is a discount compared to the large-cap MedTech category averaging around 28 times projected earnings [2]. Group 2: Market Position - The MedTech division of Abbott is a focal point for future growth, with expectations of maintaining robust growth rates, contributing to the overall positive outlook for the company [1].

Abbott Laboratories (NYSE:ABT) is one of the 12 Set-It-and-Forget-It Stocks to Buy Now. Amid a positive second quarter and a top executive sale, the company gains an expansion opportunity from Medtronic. Abbott Gains Diabetes Tech Expansion Opportunity Following Earnings Beat and Insider Sale Abbott Laboratories (NYSE:ABT) reported a 6.9% increase in sales for the second quarter of 2025. The earnings report, announced on July 17, 2025, also highlighted an Adjusted EPS of $1.26, which beat the consensus ...

About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...